EUVIMEDOdkrijte EUVIMED
Übersichtsarbeit

Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen

M P Cooreman, G Leroux-Roels, W P Paulij

Journal of Biomedical Science · 2001-05 · 8 (3) · 237-247

DOI: 10.1007/bf02256597 ↗

At a glance

Übersichtsarbeit in Journal of Biomedical Science, 2001-05. Written by M P Cooreman and 2 co-authors. Institution: Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. m.cooreman@amc.uva.nl. Cited 159 times so far (Crossref); 79 references.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Hepatitis B virus surface antigen (HBsAg) vaccination has been shown to be effective in preventing hepatitis B virus (HBV) infection. The protection is based on the induction of anti-HBs antibodies against a major cluster of antigenic epitopes of HBsAg, defined as the 'a' determinant region of small HBsAg. Prophylaxis of recurrent HBV infection in patients who have undergone liver transplantation for hepatitis B-related end-stage liver disease is achieved by the administration of hepatitis B immune globulins (HBIg) derived from HBsAg-vaccinated subjects. The anti-HBs-mediated immune pressure on HBV, however, seems to go along with the emergence and/or selection of immune escape HBV mutants that enable viral persistence in spite of adequate antibody titers. These HBsAg escape mutants harbor single or double point mutations that may significantly alter the immunological characteristics of HBsAg. Most escape mutations that influence HBsAg recognition by anti-HBs antibodies are located in the second 'a' determinant loop. Notably, HBsAg with an arginine replacement for glycine at amino acid 145 is considered the quintessential immune escape mutant because it has been isolated consistently in clinical samples of HBIg-treated individuals and vaccinated infants of chronically infected mothers. Direct binding studies with monoclonal antibodies demonstrated a more dramatic impact of this mutation on anti-HBs antibody recognition, compared with other point mutations in this antigenic domain. The clinical and epidemiological significance of these emerging HBsAg mutants will be a matter of research for years to come, especially as data available so far document that these mutants are viable and infectious strains. Strategies for vaccination programs and posttransplantation prophylaxis of recurrent hepatitis need to be developed that may prevent immune escape mutant HBV from spreading and to prevent these strains from becoming dominant during the next decennia.

Subjects

MeSH terms (MEDLINE)

Hepatitis BHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B VaccinesHepatitis B virusHumansImmunization, PassiveImmunoglobulinsMutationProtein ConformationVaccination

Substances

Hepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B VaccinesImmunoglobulinshepatitis B hyperimmune globulin

Authors and institutions

  • Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. m.cooreman@amc.uva.nl

Cite

APA

Cooreman, M. P., Leroux-Roels, G., & Paulij, W. P. (2001). Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. Journal of Biomedical Science, 8(3), 237-247. https://doi.org/10.1007/bf02256597

Vancouver

Cooreman MP, Leroux-Roels G, Paulij WP. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. Journal of Biomedical Science. 2001;8(3):237-247. doi:10.1007/bf02256597

BibTeX
@article{Cooreman2001,
  author = {Cooreman, M P and Leroux-Roels, G and Paulij, W P},
  title = {Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen},
  journal = {Journal of Biomedical Science},
  year = {2001},
  volume = {8},
  number = {3},
  pages = {237--247},
  doi = {10.1007/bf02256597}
}
Start for free →